# Tergus Pharma LLC, Durham, NC – FDA Inspections

Source: https://www.keypedia.com/companies/tergus-pharma-llc/430c8a0d-2cd5-47b6-91af-d5573fd6bda3

> Inspection records and compliance data for Tergus Pharma LLC in Durham, North Carolina. 7 FDA inspections on record, 1 Form 483, last inspected November 07, 2025.

---

## Details

- Name: Tergus Pharma LLC
- FEI Number: 3004570125
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING
- Address Line 1: 4018 Stirrup Creek Dr
- City: Durham
- State: North Carolina
- Zip Code: 27703
- Country Name: United States
- Address: 4018 Stirrup Creek Dr, Durham, North Carolina 27703, United States
- Country: United States

## Related Documents

- [FDA Inspection 1294372 - Tergus Pharma LLC - 2025-11-07](https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/7c402b5e-6481-44a8-8d02-31f2539e1a6d) — source: FDA, date: November 7, 2025
- FDA Inspection 1294372 - Tergus Pharma LLC - 2025-11-07 — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2025
- FDA Inspection 1257890 - Tergus Pharma LLC - 2024-12-13 — source: FDA, date: December 13, 2024
- [FDA Inspection 1257890 - Tergus Pharma LLC - 2024-12-13](https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/7cabe855-70e8-48e9-ad13-b875424e6e77) — classification: No Action Indicated (NAI), source: FDA, date: December 13, 2024
- [EIR - Tergus Pharma LLC - 2019-09-27](https://www.keypedia.com/records/eir/tergus-pharma-llc/0f24ca97-aecf-4772-8d4a-3138c0820c2a) — source: FDA, date: September 27, 2019
- FDA Inspection 1112674 - Tergus Pharma LLC - 2019-09-27 — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2019
- [FDA Inspection 1048636 - Tergus Pharma LLC - 2016-10-07](https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/b1e09a51-7b9a-4290-95cf-6dfd633aff9b) — source: FDA, date: October 7, 2016
- FDA Inspection 947077 - Tergus Pharma LLC - 2015-10-09 — classification: No Action Indicated (NAI), source: FDA, date: October 9, 2015
- FDA Inspection 920748 - Tergus Pharma LLC - 2015-04-02 — classification: No Action Indicated (NAI), source: FDA, date: April 2, 2015
- [FDA Inspection 697941 - Tergus Pharma LLC - 2010-11-09](https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/d68689bd-f785-4d15-8f0c-fbdf09fb2531) — classification: No Action Indicated (NAI), source: FDA, date: November 9, 2010

## Related Companies

- [Crown Laboratories Inc](https://www.keypedia.com/companies/crown-laboratories-inc/abf83f84-3545-4b6e-95fc-8294fb9e1333)
- [EMD Serono, Inc.](https://www.keypedia.com/companies/emd-serono-inc/6e52e7aa-a170-4208-a365-2f640b168ad3)
- [Raritan Pharmaceuticals, Inc.](https://www.keypedia.com/companies/raritan-pharmaceuticals-inc/31d76ce5-e5b2-4f61-b7b5-daa1a81f7cf0)
- [Mikart LLC](https://www.keypedia.com/companies/mikart-llc/f3303e07-0f87-4b83-a44d-0be8653c97bf)
- [Sunshine Lake Pharma Co., Ltd](https://www.keypedia.com/companies/sunshine-lake-pharma-co-ltd/f256b8e6-f6d3-4011-8a94-3fdb7ffcb363)
- [DSC Laboratories, Inc.](https://www.keypedia.com/companies/dsc-laboratories-inc/1cc93494-10c8-4265-8ca4-7761265d1beb)
- [Novo Nordisk A/S - G8, X9 M.FI](https://www.keypedia.com/companies/novo-nordisk-as-g8-x9-mfi/389db4db-1347-40e5-88ef-284fdcfa1a1d)
- [Tec Laboratories, Inc.](https://www.keypedia.com/companies/tec-laboratories-inc/a77617c8-46fb-4bb1-9ac3-4404cd8fae07)
- [Novo Nordisk Pharmaceutical Industries LP](https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/6bd6ea0d-568a-4f97-ba33-f6bbab29a175)
- [ABC Compounding Co., Inc.](https://www.keypedia.com/companies/abc-compounding-co-inc/ffd26af1-9fee-4ed0-acf0-9a4ac91014c2)

## Related Officers

- [Betsy C. Galliher](https://www.keypedia.com/people/betsy-c-galliher/04add63c-cbcb-42f7-b634-7c2925600bef)
- [recipient](https://www.keypedia.com/people/vijendra-nalamothu/3191bc90-25b4-492c-a975-523cc05a1e4c)